|
|
||||||||
1 Department of Molecular and Cellular Physiology, Louisiana State University Medical Center, Shreveport, Louisiana 71130-3392; and 2 Harvard Medical School, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129-2060
Myocardial
ischemia and reperfusion (MI/R) initiates a cascade of
polymorphonuclear neutrophil (PMN)-mediated injury, the magnitude of
which may be influenced by the bioavailability of nitric oxide
(NO). We investigated the role of endothelial cell nitric
oxide synthase (ecNOS) in MI/R injury by subjecting wild-type and
ecNOS-deficient (
/
) mice to 20 min of coronary artery
occlusion and 120 min of reperfusion. Myocardial infarct size
represented 20.9 ± 2.9% of the ischemic zone in wild-type mice,
whereas the ecNOS
/
mice had significantly
(P < 0.01) larger infarcts measuring 46.0 ± 3.8% of the ischemic zone. Because P-selectin is thought to
be involved with the pathogenesis of neutrophil-mediated I/R injury, we
assessed the effects of MI/R on P-selectin expression in the myocardium
of wild-type and ecNOS
/
mice. P-selectin expression
measured with a radiolabeled monoclonal antibody (MAb) technique after
MI/R in wild-type mice was 0.037 ± 0.009 µg MAb/g tissue, whereas ecNOS
/
coronary vasculature was
characterized by significantly (P < 0.05) higher P-selectin expression (0.080 ± 0.013 µg MAb/g
tissue). Histological examination of the postischemic myocardium
revealed significantly (P < 0.01)
more neutrophils in the ecNOS
/
(29.5 ± 2.5 PMN/field) compared with wild-type (5.0 ± 0.9 PMN/field) mice. A
similar trend in infarct size and neutrophil accumulation was observed
when wild-type and ecNOS
/
mice were subjected to 30 min
of ischemia and 120 min of reperfusion. These novel in vivo
findings demonstrate a cardioprotective role for ecNOS-derived NO in
the ischemic-reperfused mouse heart.
mouse; neutrophils; infarction; leukocyte adhesion molecules
This article has been cited by other articles:
![]() |
U. Landmesser, K. C. Wollert, and H. Drexler Potential novel pharmacological therapies for myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 519 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, Y. Tanoue, M. Eto, H. Baba, S. Kimura, S. Oda, K. Taniguchi, and R. Tominaga A Rho-kinase inhibitor improves cardiac function after 24-hour heart preservation. J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1586 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsuhisa, H. Otani, T. Okazaki, K. Yamashita, Y. Akita, D. Sato, A. Moriguchi, H. Imamura, and T. Iwasaka Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2473 - H2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, R. V. Donthi, J. Wang, A. J. Lange, L. J. Watson, S. P. Jones, and P. N. Epstein Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2889 - H2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fu, Z. Wang, W. L. Chen, P. K. Moore, and Y. Z. Zhu Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1545 - H1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Kaufmann, C. Lewis, A. Xie, A. Mirza-Mohd, and J. R. Lindner Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography Eur. Heart J., August 2, 2007; 28(16): 2011 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Means, C.-Y. Xiao, Z. Li, T. Zhang, J. H. Omens, I. Ishii, J. Chun, and J. H. Brown Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2944 - H2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hazarika, M. R. Van Scott, and R. M. Lust Severity of myocardial injury following ischemia-reperfusion is increased in a mouse model of allergic asthma Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H572 - H579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Elrod, J. J. M. Greer, and D. J. Lefer Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H342 - H347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Duranski, J. W. Elrod, J. W. Calvert, N. S. Bryan, M. Feelisch, and D. J. Lefer Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2980 - H2986. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Weinberg, M. Scherrer-Crosbie, M. H. Picard, B. A. Nasseri, C. MacGillivray, J. Gannon, Q. Lian, K. D. Bloch, and R. T. Lee Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1802 - H1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Altay, E. R. Gonzales, T. S. Park, and J. M. Gidday Cerebrovascular inflammation after brief episodic hypoxia: modulation by neuronal and endothelial nitric oxide synthase J Appl Physiol, March 1, 2004; 96(3): 1223 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 481 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones, J. J. M. Greer, A. K. Kakkar, P. D. Ware, R. H. Turnage, M. Hicks, R. van Haperen, R. de Crom, S. Kawashima, M. Yokoyama, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H276 - H282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wink, K. M. Miranda, T. Katori, D. Mancardi, D. D. Thomas, L. Ridnour, M. G. Espey, M. Feelisch, C. A. Colton, J. M. Fukuto, et al. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2264 - H2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pignatti and C. Stefanelli Ischemia/reperfusion-induced apoptosis: connecting nitric oxide and cell cycle regulators Cardiovasc Res, August 1, 2003; 59(2): 268 - 270. [Full Text] [PDF] |
||||
![]() |
Y. Maejima, S. Adachi, H. Ito, K. Nobori, M. Tamamori-Adachi, and M. Isobe Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity Cardiovasc Res, August 1, 2003; 59(2): 308 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tiemann, D. Weyer, P. C. Djoufack, A. Ghanem, T. Lewalter, U. Dreiner, R. Meyer, C. Grohe, and K. B. Fink Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H464 - H474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Prorock, A. Hafezi-Moghadam, V. E. Laubach, J. K. Liao, and K. Ley Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H133 - H140. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Novalija, S. G. Varadarajan, A. K. S. Camara, J. An, Q. Chen, M. L. Riess, N. Hogg, and D. F. Stowe Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H44 - H52. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Sharp, S. P. Jones, D. M. Rimmer, and D. J. Lefer Differential response to myocardial reperfusion injury in eNOS-deficient mice Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2422 - H2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bao, K. Sato, M. Li, Y. Gao, R. Abid, W. Aird, M. Simons, and M. J. Post PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated Ikappa Balpha degradation Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2612 - H2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R D Rakhit and M S Marber Nitric oxide: an emerging role in cardioprotection? Heart, October 1, 2001; 86(4): 368 - 372. [Full Text] [PDF] |
||||
![]() |
S. P. Jones, S. D. Trocha, and D. J. Lefer Cardioprotective actions of endogenous IL-10 are independent of iNOS Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H48 - H52. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones and D. J. Lefer Myocardial Reperfusion Injury: Insights Gained from Gene-Targeted Mice Physiology, December 1, 2000; 15(6): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Hoffmeyer, R. Scalia, C. R. Ross, S. P. Jones, and D. J. Lefer PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2824 - H2828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones, S. D. Trocha, M. B. Strange, D. N. Granger, C. G. Kevil, D. C. Bullard, and D. J. Lefer Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2196 - H2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Nossuli, V. Lakshminarayanan, G. Baumgarten, G. E. Taffet, C. M. Ballantyne, L. H. Michael, and M. L. Entman A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1049 - H1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kersten and D. C. Warltier Modulation of the adaptive response to myocardial ischemia by coexisting disease Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2268 - H2270. [Full Text] [PDF] |
||||
![]() |
S. P. Jones, W. G. Girod, A. J. Palazzo, D. N. Granger, M. B. Grisham, D. Jourd'Heuil, P. L. Huang, and D. J. Lefer Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1567 - H1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Sharp, S. P. Jones, D. M. Rimmer, and D. J. Lefer Differential response to myocardial reperfusion injury in eNOS-deficient mice Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2422 - H2426. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |